Significant clinical benefits.
Suitable for solid or liquid dose drugs, our transdermal technologies address unmet clinical needs, and offer:
Delivering drugs below the surface of the skin, our technology is minimally invasive, therefore leading to minimal pain or discomfort.
ACCURATE AND CONTROLLED DOSING.
Our transdermal technology allows drug dosages to be accurately administered, allowing controllable on-demand therapy, with minimal operator dependence.
Easy to use, our devices will improve compliance and therefore improve patient quality of life. Significant savings can also be made where nurses and carers were previously required for drug administration.
REDUCED SIDE EFFECTS.
Avoiding the first-pass effect of liver metabolism, our technology helps reduce side effects associated with oral drug delivery, to maximise both effectiveness and patient compliance.
Biologic drugs are prone to degradation by stomach acids if taken orally. The key alternative is a syringe and needle. Our systems allow the delivery of biologics in a minimally invasive manner, using ergonomically designed devices that will aid self-administration.